{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:16:35Z","timestamp":1771010195001,"version":"3.50.1"},"reference-count":49,"publisher":"Wiley","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mediators of Inflammation"],"published-print":{"date-parts":[[2014]]},"abstract":"<jats:p><jats:italic>Objective.<\/jats:italic>The study aim was to determine treatment persistence rates and to identify causes of discontinuation in psoriatic arthritis (PsA) and ankylosing spondylitis (AS) patients in clinical practice.<jats:italic>Methods.<\/jats:italic>Patients treated with adalimumab (ADA), etanercept (ETA), or infliximab (INF) were retrospectively included. Treatment persistence rates were analyzed by means of a stepwise logistic regression. Differences between therapy duration were assessed by means of an analysis of variance model (ANOVA), while a chi-square test was used to evaluate relationships between therapies and causes of treatment discontinuation and the administration of concomitant disease-modifying antirheumatic drugs (DMARDs) among therapies and types of disease considering completed courses of therapy versus courses that were discontinued.<jats:italic>Results.<\/jats:italic>268 patients received a total of 353 anti-TNF treatment courses (97 ADA, 180 ETA, and 76 INF). Comparison among therapies showed significant difference regarding the treatment persistence rates due to the contrast between ETA and INF (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\"><mml:mi>P<\/mml:mi><mml:mo>=<\/mml:mo><mml:mn>0.0062<\/mml:mn><\/mml:math>). We observed that 84.7% of patients were still responding after 6 months of follow-up. Comparison among diseases showed that there were significant differences between PsA and AS (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\"><mml:mi>P<\/mml:mi><mml:mo>=<\/mml:mo><mml:mn>0.0073<\/mml:mn><\/mml:math>) and PsA and PsA with predominant axial involvement (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\"><mml:mi>P<\/mml:mi><mml:mo>=<\/mml:mo><mml:mn>0.0467<\/mml:mn><\/mml:math>) in terms of duration of the therapy, while there were no significant differences with regard to the persistence rate.<jats:italic>Conclusions.<\/jats:italic>In this cohort, anti-TNF-<jats:italic>\u03b1<\/jats:italic>therapy was associated with high drug persistence rates. As in rheumatoid arthritis, switching to another anti-TNF-<jats:italic>\u03b1<\/jats:italic>agent can be an effective option when, during the treatment of AS or PsA, therapy is suspended because of inefficacy or an adverse event. Combination therapy with DMARDs was associated with a better persistence rate.<\/jats:p>","DOI":"10.1155\/2014\/862969","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T18:24:10Z","timestamp":1404843850000},"page":"1-7","source":"Crossref","is-referenced-by-count":48,"title":["Drug Retention Rates and Treatment Discontinuation among Anti-TNF-<i>\u03b1<\/i>Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice"],"prefix":"10.1155","volume":"2014","author":[{"given":"Marta","family":"Fabbroni","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-1275","authenticated-orcid":true,"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8928-2520","authenticated-orcid":true,"given":"Francesco","family":"Caso","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy"},{"name":"Rheumatology Unit, Department of Medicine DIMED, University of Padova, Via Giustiniani 2, 35128 Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Costa","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Via S. Pansini 5, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica Anna","family":"Pagano","sequence":"additional","affiliation":[{"name":"TFS Develop, Viale Parioli 12, 00197 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Frediani","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Manganelli","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Galeazzi","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2011.11.006"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110845"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120243"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1892-1"},{"issue":"4","key":"5","first-page":"680","volume":"22","year":"1995","journal-title":"Journal of Rheumatology"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120240"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/839135"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2013.105"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2568-4"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203582"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.07.016"},{"key":"12","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1517\/14656566.2013.840292","volume":"14","year":"2013","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2012.06.016"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.40"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12045"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes026"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2369-1"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2011.06.006"},{"key":"19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10067-014-2536-z","volume":"33","year":"2014","journal-title":"Clinical Rheumatology"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2378-0"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1186\/ar2562"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2007.10.007"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1002\/art.38070"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1002\/art.23471"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1002\/art.22331"},{"key":"26","first-page":"624","volume":"68","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1002\/art.22236"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.082925"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken094"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.073569"},{"issue":"11","key":"31","first-page":"2183","volume":"32","year":"2005","journal-title":"Journal of Rheumatology"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken334"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972"},{"issue":"4","key":"34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","year":"1984","journal-title":"Arthritis and Rheumatism"},{"issue":"11","key":"35","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/rheumatology\/35.11.1101","volume":"35","year":"1996","journal-title":"British Journal of Rheumatology"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200350"},{"issue":"12","key":"37","first-page":"2286","volume":"21","year":"1994","journal-title":"Journal of Rheumatology"},{"issue":"12","key":"38","first-page":"2281","volume":"21","year":"1994","journal-title":"Journal of Rheumatology"},{"issue":"9","key":"39","first-page":"1694","volume":"21","year":"1994","journal-title":"Journal of Rheumatology"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.2.127"},{"key":"41","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1016\/S0197-2456(05)80016-9","volume":"12","year":"1991","journal-title":"Controlled Clinical Trials"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.133645"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2010.05.007"},{"key":"44","first-page":"857","volume":"31","year":"2013","journal-title":"Clinical and Experimental Rheumatology"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1186\/ar1941"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep422"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.073544"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1186\/ar2670"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel149"}],"container-title":["Mediators of Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/mi\/2014\/862969.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/mi\/2014\/862969.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/mi\/2014\/862969.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T12:22:17Z","timestamp":1498134137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/mi\/2014\/862969\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":49,"alternative-id":["862969","862969"],"URL":"https:\/\/doi.org\/10.1155\/2014\/862969","relation":{},"ISSN":["0962-9351","1466-1861"],"issn-type":[{"value":"0962-9351","type":"print"},{"value":"1466-1861","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}